This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Karen A Larson - Innovator in Pharmaceutical Crystallization
Introduction
Karen A Larson is a notable inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the crystallization processes of important compounds. Her work is essential for the development of effective medications.
Latest Patents
Karen A Larson holds a patent for a process related to the crystallization of losartan potassium. This compound is an angiotensin II antagonist that is useful in treating hypertension and congestive heart failure. The patent describes a method that utilizes anti-solvent addition combined with massive seeding to achieve the desired crystal morphology and bulk physical properties necessary for successful formulation.
Career Highlights
Karen is associated with Merck & Co., Inc., a leading global healthcare company. Her work at Merck has allowed her to focus on innovative solutions that enhance drug formulation and efficacy.
Collaborations
Throughout her career, Karen has collaborated with talented individuals such as Michael T Kennedy and Erik A Dienemann. These collaborations have contributed to her success and the advancement of pharmaceutical sciences.
Conclusion
Karen A Larson's contributions to the field of pharmaceutical crystallization exemplify her dedication to innovation in medicine. Her patent on the crystallization of losartan potassium highlights her role in improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile